Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Clinical trial NCT04126317 · COMPLETED
Trial details
- NCT number
- NCT04126317
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2021-05-14
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.